FdaApplication
BLA 208583
Identifiers
- fda_app_no: BLA208583
Properties
| Property | Value |
|---|---|
| applicant_name | Novo Nordisk Inc. |
| application_type | BLA |
| approval_date | 2016-11-21 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| XULTOPHY 100/3.6 | INSULIN DEGLUDEC; LIRAGLUTIDE | 300 UNITS/3ML;10.8MG/3ML (100 UNITS/ML | Injection |
1 product